|
Charlotte W. Collins, Esq. serves as a member of the BioScrip board of directors, effective April 2005. Ms. Collins was named to this position upon consummation of the merger between MIM Corporation and Chronimed, Inc.
Ms. Collins previously served as a member of the MIM board of directors. Since January 2002, Ms. Collins has been Associate Research Professor, Director of Minority Health Policy Program, at the George Washington University School of Public Health and Health Services. Since 1996, Ms. Collins has been associated with the law firm of Powell, Goldstein, Frazer & Murphy, LLP in Washington, DC. During 1998, Ms. Collins held the position of Interim General Counsel for the District of Columbia Health and Hospitals Public Benefit Corporation. | 